Stockreport

Immunovant, Inc. (IMVT) Analysts Raise Price Targets Following Q3 Earnings Update [Yahoo! Finance]

Immunovant, Inc.  (IMVT) 
PDF its Q3 2025 results, reporting a smaller-than-anticipated quarterly loss of -$0.61 per share, surpassing consensus projections of -$0.72 by $0.11. Immunovant, Inc. (IM [Read more]